Skip to main content
Premium Trial:

Request an Annual Quote

Lipomics Partners with Joslin Diabetes Center on Biomarkers

NEW YORK (GenomeWeb News) – Lipomics Technologies today said that it is collaborating with the Joslin Diabetes Center on two studies, one of which aims to identify biomarkers for potential diagnostics.
 
The first study, on insulin-resistant patients with a family history of type 2 diabetes, aims to identify predictive markers of diabetes that Lipomics could develop into blood-based diagnostics. The second study will focus on the effects of gastric bypass surgery on insulin sensitivity.
 
West Sacramento, Calif.-based Lipomics said it will retain certain rights to develop diagnostics based on data that emerges from the two studies.
 
Other details of the agreement were not disclosed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.